Bio-Techne (NASDAQ:TECH) Downgraded to Hold Rating by Baird R W
Baird R W lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a strong-buy rating to a hold rating in a research note published on Wednesday morning,Zacks.com reports. Several other research ...
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™ in situ hybridization probes to advance ...
Bio-Techne expanded menu of RNAscope probes
Bio-Techne (TECH) announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology ...
Bio-Techne (NASDAQ:TECH) Rating Lowered to Neutral at Robert W. Baird
Bio-Techne (NASDAQ:TECH – Get Free Report) was downgraded by stock analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating in a report issued on Wednesday, Ratings reports. They ...
Barchart on MSN3d
Bio-Techne Stock Outlook: Is Wall Street Bullish or Bearish?
Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions ...
Zacks.com on MSN16d
Bio-Techne Tops Q2 Earnings & Revenue Estimates, Stock Up in Premarket
Bio-Techne TECH reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of 42 cents, which exceeded the Zacks Consensus Estimate by 10.5%. The bottom line improved from the year-ago ...
Deep Dive Into Bio-Techne Stock: Analyst Perspectives (4 Ratings)
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP Transposase mRNA for the TcBuster™ non-viral ...
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors
Shares of Bio-Techne Corp. TECH slipped 2.25% to $68.34 Tuesday, on what proved to be an all-around positive trading session ...
Bio-Techne downgraded to Neutral from Outperform at Baird
Baird analyst Catherine Ramsey Schulte downgraded Bio-Techne (TECH) to Neutral from Outperform with a price target of $68, down from $88. The ...
Morningstar2d
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
MINNEAPOLIS, Feb. 20, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope ...
Morningstar3d
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
MINNEAPOLIS, Feb. 18, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP ...